EGFR and head and neck squamous cell carcinoma: Herein, we utilized a systematic, genome-wide approach to characterize an ErbB co-regulon in head and neck squamous cell carcinomas with the goal of defining drug-gene associations that may represent action points for tumors that are putatively driven by the co-regulon.